Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07591337

SNRK & Vascular Endothelial Aging

Cardiovascular diseases pose a serious threat to public health, and their prevalence is on the rise year by year. Vascular aging is an independent risk factor for cardiovascular diseases, and endothelial cell senescence is an early event in vascular aging. Its occurrence can lead to endothelium-dependent vasodilation dysfunction, reduced vascular permeability, and the release of the senescence-associated secretory phenotype (SASP). These vascular pathological changes further damage the vascular media, leading to vascular remodeling and reduced compliance, accelerating the progression of atherosclerosis, and ultimately resulting in cardiovascular diseases such as coronary heart disease and hypertension. Recent research of the investigators has revealed that SNRK, a new member of the AMPK family of cellular energy sensors, plays a key regulatory role in vascular development. Based on this finding, the investigators propose the scientific hypothesis that SNRK responds to both physiological and pathological aging stimuli through differential mechanisms and regulates the process of endothelial cell senescence. In this study, the investigators will explore the correlation between SNRKAS and carotid vascular structure and endothelial function by measuring the levels of the SNRK upstream lncRNA (SNRKAS) in participants' peripheral blood, in conjunction with carotid ultrasound examinations. The findings will provide a solid scientific basis for elucidating new mechanisms underlying the onset and progression of vascular aging and for identifying novel therapeutic targets.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Tianjin Medical University General Hospital

Tianjin, Tianjin Municipality, 300052, China

Location status: Recruiting

Location contact

Xintong Ge, M.D.

CONTACT

[email protected]

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Aged 18-80 years, with the capacity to make decisions independently or represented by an authorized legal guardian;
  • Able to provide complete personal information, medical history, and lifestyle history (e.g., smoking and alcohol consumption history);
  • No history of severe cardiovascular disease, and deemed eligible for inclusion by a physician.

Exclusion criteria

  • Women who are pregnant or may become pregnant;
  • Patients with a history of neurological disorders, tumors, severe cardiovascular or pulmonary disease, liver failure, kidney failure, or blood disorders;
  • Patients who have undergone carotid stenting, carotid endarterectomy, or other similar procedures, or who have unilateral carotid artery occlusion due to any cause;
  • Patients who have participated in another clinical trial within the past 4 weeks;
  • Individuals deemed unsuitable for this clinical trial by the investigators.

Treatment and study plan

serum tests and carotid ultrasound test

Diagnostic Test
  • 10 mL of venous blood was drawn from each participant to measure blood lipids and serum levels of SNRKAS (using RT-qPCR), and to perform transcriptomic analysis.
  • Carotid ultrasound was used to measure circumferential strain and pulse wave velocity in both carotid arteries to assess the degree of arterial stiffness.

Primary outcomes

  1. Serum levels of SNRKAS detected by RT-PCR

    Time frame: At enrollment

    serum levels of SNRKAS (fold change)

  2. Degree of bilateral carotid artery stenosis detected by Doppler ultrasound

    Time frame: At enrollment

    Intima-media thickness (mm) and lumen diameter (mm) of bilateral common carotid artery and internal carotid artery

  3. Pulse wave velocity in both carotid arteries detected by Doppler ultrasound

    Time frame: At enrollment

    Peak systolic velocity (cm/s) of bilateral common carotid artery and internal carotid artery

Secondary outcomes

  1. Blood lipids levels detected by automated biochemical analyzer (LABOSPECT 008, Hitachi)

    Time frame: At enrollment

    Total Cholesterol (mmol/L), Triglycerides (mmol/L), High-Density Lipoprotein (mmol/L), Low-Density Lipoprotein (mmol/L)

Study contacts

Contact information is provided by the study sponsor or research team.

Xintong Ge, M.D.

CONTACT

[email protected]

86-022-60362237

Sponsors and collaborators

Lead sponsor

Tianjin Medical University

Other

Registry information

Official study title

The Association Between SNRK and Vascular Endothelial Aging

Important dates

Study start
2026
Primary completion
2029
Study completion
2029
First posted
May 15, 2026
Registry last updated
May 15, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.